title: [Genomic signature in breast cancer: Oncotype DX(®)].
authors.affiliation: Laboratoire d'anatomie pathologie, centre hospitalo-universitaire Kremlin-Bicêtre, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France. Benjamin.teig@bct.aphp.fr
authors.forename: Benjamin
authors.initials: B
authors.lastname: Teig
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000191:economics / Q000235:genetics*; D017024:Chemotherapy, Adjuvant / Q000191:economics / Q000706:statistics & numerical data; D002986:Clinical Trials as Topic; D003363:Cost Control; D004967:Estrogens; D005260:Female; D052138:Genes, Neoplasm; D018734:Genes, erbB-2; D057166:High-Throughput Screening Assays / Q000191:economics / Q000379:methods*; D006801:Humans; D015337:Multicenter Studies as Topic; D009361:Neoplasm Invasiveness / Q000235:genetics; D009363:Neoplasm Proteins / Q000235:genetics; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000188:drug therapy / Q000191:economics / Q000235:genetics; D011374:Progesterone; D012333:RNA, Messenger / Q000235:genetics*; D012334:RNA, Neoplasm / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction / Q000191:economics / Q000379:methods*; D011960:Receptors, Estrogen / Q000032:analysis / Q000235:genetics; D011980:Receptors, Progesterone / Q000032:analysis / Q000235:genetics; D012008:Recurrence; D018570:Risk Assessment; D013629:Tamoxifen / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D059467:Transcriptome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004967:Estrogens; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen; D011374:Progesterone